The investment will help the startup scale the app to include B2B services for SMEs.
Egyptian healthtech startup Chefaa has raised an undisclosed USD seven-figure amount in a Pre-Series A round. The pharmacy marketplace platform announced that the investment was in participation with longtime investor 500 Startups, Vision Ventures and Womena among others.
Chefaa is now scaling to not only cater to users, but to diversify the portfolio by providing SMEs with B2B services. The Cairo-born startup plans to expand their operations with recently-launched private and white-label products. According to Chefaa, they have so far fulfilled hundreds of thousands of prescription and non-pharmaceutical orders.
”We take pride in serving our growing base of users as well as managing their pharmacy needs. We have built our customer care centre to ensure that user experience is being managed professionally,” says Dr. Rasha Rady, the co-founder and COO of Chefaa.
The app’s services are more than apt during a pandemic, and assists users and patients to practice social distancing and have their pharmacy needs fulfilled contact-free. “In the current environment, any startup that can improve people’s lives and assist in social distancing measures is doing a service to all of us. We’re happy to be supporting Chefaa in providing people with a more efficient way to get their medication,” says Hasan Haider, Managing Partner of 500 Startups MENA.
Sign up for the daily Startup Digest.